These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31376425)

  • 1. Aurora kinase A promotes hepatitis B virus replication and expression.
    Jeong GU; Ahn BY
    Antiviral Res; 2019 Oct; 170():104572. PubMed ID: 31376425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.
    Liu X; Shi Y; Woods KW; Hessler P; Kroeger P; Wilsbacher J; Wang J; Wang JY; Li C; Li Q; Rosenberg SH; Giranda VL; Luo Y
    Neoplasia; 2008 Aug; 10(8):828-37. PubMed ID: 18670641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK.
    Hutterer C; Wandinger SK; Wagner S; Müller R; Stamminger T; Zeitträger I; Godl K; Baumgartner R; Strobl S; Marschall M
    Antiviral Res; 2013 Aug; 99(2):139-48. PubMed ID: 23648710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
    Ogura N; Ogawa K; Watashi K; Ito T; Wakita T
    Biochem Biophys Res Commun; 2018 Mar; 498(1):64-71. PubMed ID: 29481805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication.
    Kang LJ; Choi YJ; Lee SG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2612-21. PubMed ID: 24004833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
    Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
    Tsukamoto Y; Ikeda S; Uwai K; Taguchi R; Chayama K; Sakaguchi T; Narita R; Yao WL; Takeuchi F; Otakaki Y; Watashi K; Wakita T; Kato H; Fujita T
    PLoS One; 2018; 13(5):e0197664. PubMed ID: 29782545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
    Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
    BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
    Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
    J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin exerts anti-hepatitis B virus activity by inhibiting expression of minichromosome maintenance protein 7 in HepG2.2.15 cells.
    Li W; Cao F; Li J; Wang Z; Ren Y; Liang Z; Liu P
    Mol Med Rep; 2016 Dec; 14(6):5334-5342. PubMed ID: 27779671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of different PAP domains on hepatitis B virus replication].
    Guo CX; He YW; Peng C; Lei YC; Li WT
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
    Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus.
    Zhang Y; Zhang Y; Kang Y; Wang J; Liu H; Zhu H; Qin Y; Mao R; Lin X; Lu M; Zhang J
    J Virol Methods; 2014 Jun; 201():51-6. PubMed ID: 24583110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
    Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
    Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
    Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
    ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein.
    Wang J; Zhang H; Zhang Y; Jiang D; Li J; Goldmann S; Ren Q; Fei R; Wang X; Wei L
    J Med Virol; 2017 Oct; 89(10):1804-1810. PubMed ID: 28401569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.